Skip to main content
Erschienen in: European Radiology 11/2022

12.05.2022 | Chest

Incremental benefits of size-zone matrix-based radiomics features for the prognosis of lung adenocarcinoma: advantage of spatial partitioning on tumor evaluation

verfasst von: Eunjin Kim, Geewon Lee, Seung-hak Lee, Hwanho Cho, Ho Yun Lee, Hyunjin Park

Erschienen in: European Radiology | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Prognostic models of lung adenocarcinoma (ADC) can be built using radiomics features from various categories. The size-zone matrix (SZM) features have a strong biological basis related to tumor partitioning, but their incremental benefits have not been fully explored. In our study, we aimed to evaluate the incremental benefits of SZM features for the prognosis of lung ADC.

Methods

A total of 298 patients were included and their pretreatment computed tomography images were analyzed in fivefold cross-validation. We built a risk model of overall survival using SZM features and compared it with a conventional radiomics risk model and a clinical variable-based risk model. We also compared it with other models incorporating various combinations of SZM features, other radiomics features, and clinical variables. A total of seven risk models were compared and evaluated using the hazard ratio (HR) on the left-out test fold.

Results

As a baseline, the clinical variable risk model showed an HR of 2.739. Combining the radiomics signature with SZM feature was better (HR 4.034) than using radiomics signature alone (HR 3.439). Combining radiomics signature, SZM feature, and clinical variable (HR 6.524) fared better than just combining radiomics signature and clinical variables (HR 4.202). These results confirmed the added benefits of SZM features for prognosis in lung ADC.

Conclusion

Combining SZM feature with the radiomics signature was better than using the radiomics signature alone and the benefits of SZM features were maintained when clinical variables were added confirming the incremental benefits of SZM features for lung ADC prognosis.

Key Points

• Size-zone matrix (SZM) features provide incremental benefits for the prognosis of lung adenocarcinoma.
• Combining the radiomics signature with SZM features performed better than using a radiomics signature alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:1–9 Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:1–9
2.
Zurück zum Zitat Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762CrossRef Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762CrossRef
3.
Zurück zum Zitat Kargl J, Busch SE, Yang GHY et al (2017) Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nat Commun 8:1–11CrossRef Kargl J, Busch SE, Yang GHY et al (2017) Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nat Commun 8:1–11CrossRef
4.
Zurück zum Zitat Sacconi B, Anzidei M, Leonardi A et al (2017) Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates. Clin Radiol 72:443–450CrossRef Sacconi B, Anzidei M, Leonardi A et al (2017) Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates. Clin Radiol 72:443–450CrossRef
5.
Zurück zum Zitat Chen B, Zhang R, Gan Y et al (2017) Development and clinical application of radiomics in lung cancer. Radiat Oncol 12:1–8CrossRef Chen B, Zhang R, Gan Y et al (2017) Development and clinical application of radiomics in lung cancer. Radiat Oncol 12:1–8CrossRef
6.
Zurück zum Zitat Fornacon-Wood I, Faivre-Finn C, O’Connor JPB, Price GJ (2020) Radiomics as a personalized medicine tool in lung cancer: separating the hope from the hype. Lung Cancer 146:197–208CrossRef Fornacon-Wood I, Faivre-Finn C, O’Connor JPB, Price GJ (2020) Radiomics as a personalized medicine tool in lung cancer: separating the hope from the hype. Lung Cancer 146:197–208CrossRef
7.
Zurück zum Zitat Ganeshan B, Goh V, Mandeville HC et al (2013) Non–small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326–336CrossRef Ganeshan B, Goh V, Mandeville HC et al (2013) Non–small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326–336CrossRef
8.
Zurück zum Zitat Song SH, Park H, Lee G et al (2017) Imaging phenotyping using radiomics to predict micropapillary pattern within lung adenocarcinoma. J Thorac Oncol 12:624–632CrossRef Song SH, Park H, Lee G et al (2017) Imaging phenotyping using radiomics to predict micropapillary pattern within lung adenocarcinoma. J Thorac Oncol 12:624–632CrossRef
9.
Zurück zum Zitat Hawkins SH, Korecki JN, Balagurunathan Y et al (2014) Predicting outcomes of nonsmall cell lung cancer using CT image features. IEEE access 2:1418–1426CrossRef Hawkins SH, Korecki JN, Balagurunathan Y et al (2014) Predicting outcomes of nonsmall cell lung cancer using CT image features. IEEE access 2:1418–1426CrossRef
10.
Zurück zum Zitat Gevaert O, Xu J, Hoang CD et al (2012) Non–small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data—methods and preliminary results. Radiology 264:387–396CrossRef Gevaert O, Xu J, Hoang CD et al (2012) Non–small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data—methods and preliminary results. Radiology 264:387–396CrossRef
11.
Zurück zum Zitat Cook GJR, Yip C, Siddique M et al (2013) Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54:19–26CrossRef Cook GJR, Yip C, Siddique M et al (2013) Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54:19–26CrossRef
12.
Zurück zum Zitat Grove O, Berglund AE, Schabath MB et al (2015) Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. PLoS One 10:e0118261CrossRef Grove O, Berglund AE, Schabath MB et al (2015) Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. PLoS One 10:e0118261CrossRef
13.
Zurück zum Zitat Ganeshan B, Panayiotou E, Burnand K et al (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRef Ganeshan B, Panayiotou E, Burnand K et al (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRef
14.
Zurück zum Zitat Alilou M, Beig N, Orooji M et al (2017) An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT. Med Phys 44:3556–3569CrossRef Alilou M, Beig N, Orooji M et al (2017) An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT. Med Phys 44:3556–3569CrossRef
15.
Zurück zum Zitat Coroller TP, Agrawal V, Huynh E et al (2017) Radiomic-based pathological response prediction from primary tumors and lymph nodes in NSCLC. J Thorac Oncol 12:467–476CrossRef Coroller TP, Agrawal V, Huynh E et al (2017) Radiomic-based pathological response prediction from primary tumors and lymph nodes in NSCLC. J Thorac Oncol 12:467–476CrossRef
16.
Zurück zum Zitat Lee HY, Lee SW, Lee KS et al (2015) Role of CT and PET imaging in predicting tumor recurrence and survival in patients with lung adenocarcinoma: a comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. J Thorac Oncol 10:1785–1794CrossRef Lee HY, Lee SW, Lee KS et al (2015) Role of CT and PET imaging in predicting tumor recurrence and survival in patients with lung adenocarcinoma: a comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. J Thorac Oncol 10:1785–1794CrossRef
17.
Zurück zum Zitat Palumbo B, Bianconi F, Palumbo I et al (2020) Value of shape and texture features from 18F-FDG PET/CT to discriminate between benign and malignant solitary pulmonary nodules: an experimental evaluation. Diagnostics 10:696CrossRef Palumbo B, Bianconi F, Palumbo I et al (2020) Value of shape and texture features from 18F-FDG PET/CT to discriminate between benign and malignant solitary pulmonary nodules: an experimental evaluation. Diagnostics 10:696CrossRef
18.
Zurück zum Zitat Cho H, Lee HY, Kim E et al (2021) Radiomics-guided deep neural networks stratify lung adenocarcinoma prognosis from CT scans. Commun Biol 4:1–12CrossRef Cho H, Lee HY, Kim E et al (2021) Radiomics-guided deep neural networks stratify lung adenocarcinoma prognosis from CT scans. Commun Biol 4:1–12CrossRef
19.
Zurück zum Zitat Tunali I, Hall LO, Napel S et al (2019) Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions. Med Phys 46:5075–5085CrossRef Tunali I, Hall LO, Napel S et al (2019) Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions. Med Phys 46:5075–5085CrossRef
20.
Zurück zum Zitat Bianconi F, Palumbo I, Spanu A et al (2020) PET/CT radiomics in lung cancer: an overview. Appl Sci 10:1718CrossRef Bianconi F, Palumbo I, Spanu A et al (2020) PET/CT radiomics in lung cancer: an overview. Appl Sci 10:1718CrossRef
21.
Zurück zum Zitat Thibault G, Fertil B, Navarro C et al (2013) Shape and texture indexes application to cell nuclei classification. Int J Pattern Recognit Artif Intell 27:1357002CrossRef Thibault G, Fertil B, Navarro C et al (2013) Shape and texture indexes application to cell nuclei classification. Int J Pattern Recognit Artif Intell 27:1357002CrossRef
22.
Zurück zum Zitat Khodabakhshi Z, Mostafaei S, Arabi H et al (2021) Non-small cell lung carcinoma histopathological subtype phenotyping using high-dimensional multinomial multiclass CT radiomics signature. Comput Biol Med 136:104752CrossRef Khodabakhshi Z, Mostafaei S, Arabi H et al (2021) Non-small cell lung carcinoma histopathological subtype phenotyping using high-dimensional multinomial multiclass CT radiomics signature. Comput Biol Med 136:104752CrossRef
23.
Zurück zum Zitat D’Antonoli TA, Farchione A, Lenkowicz J et al (2020) CT radiomics signature of tumor and peritumoral lung parenchyma to predict nonsmall cell lung cancer postsurgical recurrence risk. Acad Radiol 27:497–507CrossRef D’Antonoli TA, Farchione A, Lenkowicz J et al (2020) CT radiomics signature of tumor and peritumoral lung parenchyma to predict nonsmall cell lung cancer postsurgical recurrence risk. Acad Radiol 27:497–507CrossRef
24.
Zurück zum Zitat Abdurixiti M, Nijiati M, Shen R et al (2021) Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review. Br J Radiol 94:20201272CrossRef Abdurixiti M, Nijiati M, Shen R et al (2021) Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review. Br J Radiol 94:20201272CrossRef
25.
Zurück zum Zitat O’Connor JPB, Rose CJ, Waterton JC et al (2015) Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res 21:249–257CrossRef O’Connor JPB, Rose CJ, Waterton JC et al (2015) Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res 21:249–257CrossRef
26.
Zurück zum Zitat Park H, Sholl LM, Hatabu H et al (2019) Imaging of precision therapy for lung cancer: current state of the art. Radiology 293:15–29CrossRef Park H, Sholl LM, Hatabu H et al (2019) Imaging of precision therapy for lung cancer: current state of the art. Radiology 293:15–29CrossRef
27.
Zurück zum Zitat Chetan MR, Gleeson FV (2021) Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol 31:1049–1058CrossRef Chetan MR, Gleeson FV (2021) Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol 31:1049–1058CrossRef
28.
Zurück zum Zitat Junttila MR, De Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501:346–354CrossRef Junttila MR, De Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501:346–354CrossRef
29.
Zurück zum Zitat Miles K, Williams R (2008) Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 8:81CrossRef Miles K, Williams R (2008) Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 8:81CrossRef
30.
Zurück zum Zitat Rankin EB, Giaccia AJ (2016) Hypoxic control of metastasis. Science 352:175–180 Rankin EB, Giaccia AJ (2016) Hypoxic control of metastasis. Science 352:175–180
31.
Zurück zum Zitat Zhao Y, Fu X, Lopez JI et al (2021) Selection of metastasis competent subclones in the tumour interior. Nat Ecol Evol:1–13 Zhao Y, Fu X, Lopez JI et al (2021) Selection of metastasis competent subclones in the tumour interior. Nat Ecol Evol:1–13
32.
Zurück zum Zitat Altorki NK, Markowitz GJ, Gao D et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 19:9–31CrossRef Altorki NK, Markowitz GJ, Gao D et al (2019) The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 19:9–31CrossRef
33.
Zurück zum Zitat Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309–322CrossRef Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309–322CrossRef
34.
Zurück zum Zitat Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125:5591–5596CrossRef Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125:5591–5596CrossRef
35.
Zurück zum Zitat Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437CrossRef Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437CrossRef
36.
Zurück zum Zitat Banat G-A, Tretyn A, Pullamsetti SS et al (2015) Immune and inflammatory cell composition of human lung cancer stroma. PLoS One 10:e0139073CrossRef Banat G-A, Tretyn A, Pullamsetti SS et al (2015) Immune and inflammatory cell composition of human lung cancer stroma. PLoS One 10:e0139073CrossRef
37.
Zurück zum Zitat Carter BW, Halpenny DF, Ginsberg MS et al (2017) Immunotherapy in non–small cell lung cancer treatment. J Thorac Imaging 32:300–312CrossRef Carter BW, Halpenny DF, Ginsberg MS et al (2017) Immunotherapy in non–small cell lung cancer treatment. J Thorac Imaging 32:300–312CrossRef
38.
Zurück zum Zitat Berenguer R, Pastor-Juan MDR, Canales-Vázquez J et al (2018) Radiomics of CT features may be nonreproducible and redundant: influence of CT acquisition parameters. Radiology 288:407–415CrossRef Berenguer R, Pastor-Juan MDR, Canales-Vázquez J et al (2018) Radiomics of CT features may be nonreproducible and redundant: influence of CT acquisition parameters. Radiology 288:407–415CrossRef
39.
Zurück zum Zitat Mackin D, Fave X, Zhang L et al (2015) Measuring CT scanner variability of radiomics features. Invest Radiol 50:757CrossRef Mackin D, Fave X, Zhang L et al (2015) Measuring CT scanner variability of radiomics features. Invest Radiol 50:757CrossRef
Metadaten
Titel
Incremental benefits of size-zone matrix-based radiomics features for the prognosis of lung adenocarcinoma: advantage of spatial partitioning on tumor evaluation
verfasst von
Eunjin Kim
Geewon Lee
Seung-hak Lee
Hwanho Cho
Ho Yun Lee
Hyunjin Park
Publikationsdatum
12.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 11/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08818-z

Weitere Artikel der Ausgabe 11/2022

European Radiology 11/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.